Radiopharm Theranostics (ASX:RAD) Pre-Tax Income : A$-46.79 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Radiopharm Theranostics Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Radiopharm Theranostics's pretax income for the six months ended in Dec. 2023 was A$-24.73 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was A$-46.79 Mil. Radiopharm Theranostics's pretax margin was %.

During the past 2 years, Radiopharm Theranostics's highest Pretax Margin was -11840.07%. The lowest was -336611.11%. And the median was -174225.59%.

Radiopharm Theranostics Pre-Tax Income Historical Data

The historical data trend for Radiopharm Theranostics's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Radiopharm Theranostics Pre-Tax Income Chart

Radiopharm Theranostics Annual Data

Trend

Jun22

Jun23

Pre-Tax Income

-30.30

-34.57

Radiopharm Theranostics Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
Pre-Tax Income	-17.39	-12.90	-12.51	-22.06	-24.73

Competitive Comparison of Radiopharm Theranostics's Pre-Tax Income

For the Biotechnology subindustry, Radiopharm Theranostics's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Radiopharm Theranostics's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Radiopharm Theranostics's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Radiopharm Theranostics's Pre-Tax Income falls into.

Radiopharm Theranostics Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Radiopharm Theranostics's Pretax Income for the fiscal year that ended in Jun. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-34.508	+	-0.124	+	-0.086	+	0.145	+	0
	=	-34.57

Radiopharm Theranostics's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-24.702	+	-1.558	+	-0.037	+	0	+	1.57
	=	-24.73

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-46.79 Mil.

Radiopharm Theranostics (ASX:RAD) Pre-Tax Income Explanation

Radiopharm Theranostics's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-24.727	/	0
	=	%

During the past 2 years, Radiopharm Theranostics's highest Pretax Margin was -11840.07%. The lowest was -336611.11%. And the median was -174225.59%.

Radiopharm Theranostics Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Radiopharm Theranostics's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Radiopharm Theranostics (ASX:RAD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Radiopharm Theranostics Ltd (ASX:RAD) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

RDPTF:USA

Address

62 Lygon Street, Level 3, Carlton South, Melbourne, VIC, AUS, 3053

Website

https://www.radiopharmtheranostics.com

Radiopharm Theranostics Ltd is a Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialisation of health technologies.

Radiopharm Theranostics (ASX:RAD) Headlines

No Headlines